Pfizer Inc. (NYSE:PFE)

The period under review demonstrates significant fluctuations in economic profit. Net operating profit after taxes (NOPAT) exhibited substantial growth initially, followed by a considerable decline and subsequent recovery, though not to initial levels. Invested capital increased markedly before decreasing and stabilizing. The cost of capital remained relatively stable throughout the period, with a slight initial increase followed by a decrease and leveling off.

Economic Profit Trend

Economic profit showed a strong upward trend from 2021 to 2022, increasing from US$9,979 million to US$20,174 million. However, a dramatic reversal occurred in 2023, resulting in an economic loss of US$14,388 million. This negative trend continued, albeit at a reduced magnitude, in 2024 and 2025, with economic losses of US$4,294 million and US$4,876 million respectively. The decline in economic profit is primarily attributable to the significant decrease in NOPAT in 2023.

NOPAT Analysis

NOPAT increased substantially from US$18,394 million in 2021 to US$31,018 million in 2022. A substantial decrease was then observed in 2023, with NOPAT falling to a loss of US$1,277 million. NOPAT recovered somewhat in 2024 and 2025, reaching US$7,374 million and US$7,193 million, respectively, but remained below the 2022 peak.

Invested Capital and Cost of Capital Relationship

Invested capital increased from US$87,670 million in 2021 to US$110,746 million in 2022, and further to US$154,882 million in 2023. It then decreased to US$135,342 million in 2024 and stabilized at US$139,753 million in 2025. The cost of capital was 9.60% in 2021, rose to 9.79% in 2022, then decreased to 8.47% in 2023, and subsequently increased slightly to 8.62% and 8.64% in 2024 and 2025. The increase in invested capital, coupled with a relatively stable cost of capital, likely contributed to the initial increase in economic profit, while the subsequent decrease in NOPAT overwhelmed the effect of the cost of capital reduction in later years.

Overall, the period was characterized by a shift from substantial economic profit generation to consistent economic losses. The primary driver of this change was a significant decline in NOPAT, despite fluctuations in invested capital and a relatively stable cost of capital.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The economic spread ratio exhibited a fluctuating pattern over the five-year period. Initially, the ratio demonstrated substantial growth, followed by a significant decline into negative territory, and then stabilized at a consistently negative level.

Economic Spread Ratio Trend

In 2021, the economic spread ratio stood at 11.38%. This figure increased considerably to 18.22% in 2022, indicating a widening spread between returns generated and the cost of capital. However, a dramatic reversal occurred in 2023, with the ratio plummeting to -9.29%. This negative value persisted in subsequent years, reaching -3.17% in 2024 and -3.49% in 2025. The consistent negativity suggests that returns generated from invested capital were insufficient to cover the cost of that capital during those periods.

The economic spread ratio’s movement correlates with changes in economic profit. The substantial increase in the ratio from 2021 to 2022 aligns with the significant growth in economic profit during the same timeframe. Conversely, the sharp decline in the ratio in 2023 corresponds with the substantial negative economic profit reported for that year. The stabilization of the ratio at negative levels in 2024 and 2025 mirrors the relatively consistent negative economic profit observed during those years.

Invested Capital and Economic Spread

Invested capital increased from US$87,670 million in 2021 to US$154,882 million in 2023. While invested capital decreased slightly to US$135,342 million in 2024, it rose again to US$139,753 million in 2025. Despite the overall increase in invested capital, the economic spread ratio remained negative in the latter three years, indicating that the increased capital deployment did not translate into sufficient returns to offset its cost.

The shift from positive to negative economic spread ratios suggests a potential deterioration in the efficiency of capital allocation or an increase in the cost of capital. Continued monitoring of these trends is warranted to assess the underlying drivers and potential implications for long-term value creation.

The economic profit margin exhibited significant fluctuations over the five-year period. Initially positive, it transitioned to negative values, indicating a decline in economic profitability. A detailed examination of the trends reveals a clear shift in the company’s ability to generate returns exceeding its cost of capital.

Economic Profit Margin Trend

In 2021, the economic profit margin stood at 12.15%. This represents a substantial return on revenues above the cost of capital. The margin increased considerably in 2022, reaching 19.94%, suggesting improved operational efficiency and/or favorable market conditions. However, a dramatic reversal occurred in 2023, with the margin plummeting to -24.16%. This indicates that the company’s economic profit was significantly negative, meaning returns were substantially below the cost of capital. The margin remained negative in 2024 and 2025, at -6.75% and -7.79% respectively, although the magnitude of the loss lessened slightly.

The movement in economic profit directly correlates with the economic profit margin. Positive economic profit values in 2021 and 2022 align with the positive margins observed in those years. The substantial decline in economic profit to negative values in 2023, 2024, and 2025 is mirrored by the corresponding negative economic profit margins. This suggests that the underlying drivers of profitability – revenues, costs, and capital charges – experienced a significant adverse shift beginning in 2023.

Revenue Impact

Revenues increased from US$82,145 million in 2021 to US$101,175 million in 2022, coinciding with the peak in economic profit margin. However, revenues then decreased substantially to US$59,553 million in 2023 and remained relatively stable at US$63,627 million and US$62,579 million in 2024 and 2025, respectively. This revenue decline likely contributed significantly to the negative economic profit margin observed from 2023 onwards.

The sustained negative economic profit margin from 2023 through 2025 warrants further investigation. A comprehensive analysis of the factors contributing to the decline in revenues and the potential increase in the cost of capital is recommended to understand the root causes and develop strategies to restore economic profitability.